Scientists test drug safety in failing livers
NCT ID NCT03664544
Summary
This study aimed to understand how a drug called MCI-186 is processed by the body in people with severe liver disease compared to healthy people. It involved 12 participants who received a single dose, and researchers closely measured drug levels in their blood. The goal was to gather safety and dosing information for future studies in patients with liver problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Centre
Prague, Czechia
-
Investigational Centre
Miskolc, Hungary
-
Investigational Centre
Bratislava, Slovakia
Conditions
Explore the condition pages connected to this study.